ABCuro finishes enrolling participants for phase 2/3 IBM treatment trial – Pharmafile

ABCuro finishes enrolling participants for phase 2/3 IBM treatment trial – Pharmafile

Abcuro, a company specializing in musculoskeletal disorders, has recently completed enrollment for its MUSCLE registration phase 2/3 clinical trial. This trial is focused on evaluating the effectiveness of ulviprubart (ABC008) in treating inclusion body myositis (IBM), a rare and debilitating condition with no current treatment options. The trial is a global, randomized, double-blind, placebo-controlled study … Read more

Stock market today: Wall Street finishes another successful week as Nvidia experiences a decline

Stock market today: Wall Street finishes another successful week as Nvidia experiences a decline

U.S. stocks ended the week with a small dip, but the S&P 500 remained near its all-time high, ending its eighth winning week out of nine. The Dow Jones Industrial Average saw a slight rise, while the Nasdaq composite fell. Nvidia’s stock took a hit, dragging down the market after rising over 1,000% since October … Read more

Symantec, a subsidiary of Broadcom (AVGO), finishes assessment in Australia.

Symantec, a subsidiary of Broadcom (AVGO), finishes assessment in Australia.

Broadcom’s Symantec cybersecurity solutions have achieved a major milestone by completing the IRAP evaluation, ensuring they meet the highest security standards required by the Australian Government. This comes at a time when cyber threats, especially ransomware attacks, are on the rise, emphasizing the need for robust cybersecurity measures to protect critical information and infrastructure. The … Read more